Showing results (381-390 of 666) with videos related to
Sort By:
Pageof 67
Gut|December 1, 1993
Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variablesJ Camps, S Crisóstomo, M García-Granero, et al.Digestive Diseases and Sciences|July 1, 1997
Enhanced urinary excretion of cGMP in liver cirrhosis. Relationship to hemodynamic changes, neurohormonal activation, and urinary sodium excretionC M Fernández-Rodriguez, J Prieto, J Quiroga, et al.Antimicrobial Agents and Chemotherapy|June 1, 1997
In vitro assessment of the effect of clavulanic acid at concentrations achieved in human serum on the bactericidal activity of amoxicillin at physiological concentrations against Staphylococcus aureus: implications for dosage regimensL Aguilar, M Martín, I P Balcabao, et al.Journal of the American College of Cardiology|March 1, 1985
Left ventricular function after myocardial infarction: clinical and angiographic correlationsA Cortina, J A Ambrose, J Prieto-Granada, et al.Vox Sanguinis|July 14, 2026
Design, development and implementation of a new transfusion safety system at the Banc de Sang i Teixits in Catalonia (Spain)C Otín-Aparicio, C Aguilar-García, L Carbonell-Cabeza, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 19, 2001
Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinomaJ I Herrero, B Sangro, J Quiroga, et al.Hepatology (Baltimore, Md.)|October 27, 2001
Nuclear factor-kappa B in the liver of patients with chronic hepatitis C: decreased RelA expression is associated with enhanced fibrosis progressionP Boya, E Larrea, I Sola, et al.Brain Research|June 22, 2019
Photobiomodulation rescues cognitive flexibility in early stressed subjectsMaría Banqueri, Juan A Martínez, Miguel J Prieto, et al.Gut|August 15, 2000
Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiologyC Berasain, M Betés, A Panizo, et al.Gut|January 5, 2002
Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignanciesV Schmitz, C Qian, J Ruiz, et al.Pageof 67